Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing...more
Time Frame | ILMN | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.12% | 1.55% | -0.66% |
1-Month Return | -0.77% | 1.02% | 2.29% |
3-Month Return | -2.7% | 9.09% | 8.84% |
6-Month Return | 4.04% | 15.34% | 22.28% |
1-Year Return | -36.33% | 17.46% | 32.44% |
3-Year Return | -64.89% | 31.65% | 36.75% |
5-Year Return | -54.09% | 78.06% | 100.86% |
10-Year Return | -3% | 199.61% | 237.34% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 3.54B | 3.24B | 4.53B | 4.58B | 4.50B | [{"date":"2019-12-31","value":77.29,"profit":true},{"date":"2020-12-31","value":70.66,"profit":true},{"date":"2021-12-31","value":98.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.25,"profit":true}] |
Cost of Revenue | 1.08B | 1.04B | 1.37B | 1.61B | 1.76B | [{"date":"2019-12-31","value":61.14,"profit":true},{"date":"2020-12-31","value":58.86,"profit":true},{"date":"2021-12-31","value":77.95,"profit":true},{"date":"2022-12-31","value":91.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 2.47B | 2.20B | 3.15B | 2.97B | 2.74B | [{"date":"2019-12-31","value":78.22,"profit":true},{"date":"2020-12-31","value":69.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.23,"profit":true},{"date":"2023-12-31","value":87,"profit":true}] |
Gross Margin | 69.63% | 68.01% | 69.69% | 64.83% | 60.92% | [{"date":"2019-12-31","value":99.92,"profit":true},{"date":"2020-12-31","value":97.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.04,"profit":true},{"date":"2023-12-31","value":87.43,"profit":true}] |
Operating Expenses | 1.48B | 1.62B | 3.28B | 7.15B | 2.97B | [{"date":"2019-12-31","value":20.72,"profit":true},{"date":"2020-12-31","value":22.7,"profit":true},{"date":"2021-12-31","value":45.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.48,"profit":true}] |
Operating Income | 985.00M | 393.00M | (123.00M) | (4.18B) | (1.07B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":39.9,"profit":true},{"date":"2021-12-31","value":-12.49,"profit":false},{"date":"2022-12-31","value":-424.26,"profit":false},{"date":"2023-12-31","value":-108.53,"profit":false}] |
Total Non-Operating Income/Expense | 156.00M | 455.00M | 946.00M | (8.84B) | (67.00M) | [{"date":"2019-12-31","value":16.49,"profit":true},{"date":"2020-12-31","value":48.1,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-934.88,"profit":false},{"date":"2023-12-31","value":-7.08,"profit":false}] |
Pre-Tax Income | 1.12B | 856.00M | 884.00M | (4.34B) | (1.12B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":76.57,"profit":true},{"date":"2021-12-31","value":79.07,"profit":true},{"date":"2022-12-31","value":-387.84,"profit":false},{"date":"2023-12-31","value":-99.91,"profit":false}] |
Income Taxes | 128.00M | 200.00M | 122.00M | 68.00M | 44.00M | [{"date":"2019-12-31","value":64,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61,"profit":true},{"date":"2022-12-31","value":34,"profit":true},{"date":"2023-12-31","value":22,"profit":true}] |
Income After Taxes | 990.00M | 656.00M | 762.00M | (4.40B) | (1.16B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.26,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":-444.85,"profit":false},{"date":"2023-12-31","value":-117.27,"profit":false}] |
Income From Continuous Operations | 990.00M | 656.00M | 762.00M | (4.40B) | (1.16B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.26,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":-444.85,"profit":false},{"date":"2023-12-31","value":-117.27,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 1.00B | 656.00M | 762.00M | (4.40B) | (1.16B) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":65.47,"profit":true},{"date":"2021-12-31","value":76.05,"profit":true},{"date":"2022-12-31","value":-439.52,"profit":false},{"date":"2023-12-31","value":-115.87,"profit":false}] |
EPS (Diluted) | 6.58 | 4.50 | 5.96 | 2.12 | 0.87 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.39,"profit":true},{"date":"2021-12-31","value":90.58,"profit":true},{"date":"2022-12-31","value":32.22,"profit":true},{"date":"2023-12-31","value":13.22,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ILMN | |
---|---|
Cash Ratio | 0.67 |
Current Ratio | 1.66 |
Quick Ratio | 1.29 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ILMN | |
---|---|
ROA (LTM) | -0.53% |
ROE (LTM) | -18.81% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ILMN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.43 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.57 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 1.76 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ILMN | |
---|---|
Trailing PE | NM |
Forward PE | 133.33 |
P/S (TTM) | 4.72 |
P/B | 3.70 |
Price/FCF | 124 |
EV/R | 4.99 |
EV/Ebitda | NM |
PEG | NM |
Apple CEO Tim Cook takes a selfie with an attendee during an event on September 10, 2019, on Apple’s Cupertino, California campus. | Justin Sullivan/Getty Images Does Apple have a monopoly on smartphones? The Justice Department thinks so. The Biden administration filed a sweeping antitrust lawsuit against Apple Thursday that targets a product that has long been the major revenue driver for the company’s $2.76 trillion business: the iPhone. The Department of Justice, joined by 16 state attorneys general, accused Apple in a New Jersey federal court of maintaining a monopoly on the US market for smartphones, of which the iPhone makes up 65 percent . The complaint alleges that Apple has deliberately thwarted apps, products, and services that would make it easier for users to switch from the iPhone to other smartphones and lower costs for consumers and developers. The company responded in a public statement Thursday that the lawsuit sets a “dangerous precedent, empowering government to take a heavy hand in designing people’s technology.” Apple was one of the last remaining big tech companies that had yet to be hit with an antitrust suit of this magnitude: There are also pending suits against Facebook parent Meta , Amazon , and Google . “Antitrust has changed and is essentially back in an FDR-style,” said Tim Wu , a professor at Columbia Law School and architect of the Biden administration’s antitrust policies . “I think a signature of the FDR-style antitrust was that they didn’t play around the edges.
The company''s chances for winning an important legal battle have improved dramatically.
Quantum-Si Incorporated (Nasdaq: QSI) appoints Paula Dowdy, a seasoned executive with 35+ years of experience, to its Board of Directors. Dowdy''s expertise in life sciences and technology industries, including roles at Illumina and Cisco Systems, brings valuable insights to Quantum-Si''s growth strategy and global operations.
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at
BRUSSELS (Reuters) - Europe''s top court should back U.S. gene sequencing company Illumina''s appeal against the EU antitrust regulators'' review of its …
Billionaire investor Carl Icahn developed a reputation as a corporate raider in the 1980s but is better known today as a shareholder activist. He buys large stakes in undervalued companies to push for changes, often through gaining seats on boards of directors. Most recently Icahn won seats on JetBlue Airways (NASDAQ: JBLU ) board just days after disclosing a 10% stake in the airline. He was also using his access to Illumina ‘s (NASDAQ: ILMN ) board through one of his portfolio managers to sue the biotech’s directors for breach of duty violations. Icahn Enterprises (NYSE: IEP ) is a master limited partnership (MLP) that has $16 billion in assets. It is really a diversified holding company with its assets divided between investments, automotive, food packaging, real estate, home fashion and pharmaceuticals. Virtually all of its assets and liabilities are owned by Icahn Enterprises Holdings , which conducts all of IEP’s operations. Because it doesn’t want to be classified as an investment company, no more than 40% of IEP’s total assets can be invested in investment securities.
NORTHAMPTON, MA / ACCESSWIRE / March 18, 2024 / Illumina:At Galatea Bio, Carlos D. Bustamante enriches the diversity of genomic datasets and brings precision medicine to underserved populationsOrig…
Illumina Inc (ILMN) share price today is $138.68
Yes, Indians can buy shares of Illumina Inc (ILMN) on Vested. To buy
Yes, you can purchase fractional shares of Illumina Inc (ILMN) via the Vested app. You can start investing in Illumina Inc (ILMN) with a minimum investment of $1.
You can invest in shares of Illumina Inc (ILMN) via Vested in three simple steps:
The 52-week high price of Illumina Inc (ILMN) is 233.42. The 52-week low price of Illumina Inc (ILMN) is 89.
The price-to-earnings (P/E) ratio of Illumina Inc (ILMN) is NM
The price-to-book (P/B) ratio of Illumina Inc (ILMN) is 3.70
The dividend yield of Illumina Inc (ILMN) is 0.00%
The market capitalization of Illumina Inc (ILMN) is $22.04B
The stock symbol (or ticker) of Illumina Inc is ILMN